HILARY SULLIVAN: Open Payments
NPI 1528692480 · WALLINGFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,373 in 194 payments from 24 companies in 2025. Trend: 2023 $3,214 · 2024 $4,085 · 2025 $4,373
Food & beverage: $4,373
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $655 |
| ViiV Healthcare Company | 18 | $615 |
| Indivior Inc. | 24 | $432 |
| Axsome Therapeutics, Inc. | 22 | $355 |
| Lilly USA, LLC | 9 | $314 |
| Gilead Sciences, Inc. | 12 | $313 |
| AstraZeneca Pharmaceuticals LP | 11 | $241 |
| Janssen Pharmaceuticals, Inc | 9 | $208 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 14 | $186 |
| Alkermes, Inc. | 7 | $167 |
Products named: APRETUDE, SUBLOCADE, QULIPTA, UBRELVY, Sunosi, SPRAVATO, MOUNJARO, VIVITROL.
Industry payments across CT — which companies pay providers there.
